Apotex Facility in India Flagged for GMP Non-Compliance

Drug Industry Daily
A A
An Apotex Research facility in Bangalore, India was cited for non-compliance with GMP requirements after an inspection in November by the UK’s Medicines and Healthcare products Regulatory Agency revealed non-sterile conditions, packaging issues, and inadequate testing.

To View This Article:

Login

Subscribe To Drug Industry Daily